Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer.
about
Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastasesAdjuvant chemotherapy for resected colorectal cancer metastases: Literature review and meta-analysisEfficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsDevelopment of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panelMeta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents.Effect of angiogenesis inhibitor bevacizumab on survival in patients with cancer: a meta-analysis of the published literature.Safety of bevacizumab in treating metastatic colorectal cancer: a systematic review and meta-analysis of all randomized clinical trials.Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver.Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results?Ziv-aflibercept in metastatic colorectal cancerProspective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials.KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastasesPhase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.Preoperative imaging for hepatic resection of colorectal cancer metastasis.What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer.Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.Modern prospection for hepatic arterial infusion chemotherapy in malignancies with liver metastasesOccurrence of hepatotoxicity with pazopanib and other anti-VEGF treatments for renal cell carcinoma: an observational study utilizing a distributed database network.Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy.Impact of Systemic Therapy and Recurrence Pattern on Survival Outcome after Radiofrequency Ablation for Colorectal Liver Metastases.Simultaneous surgery for primary colorectal cancer and metastatic lesions?Meeting the biologic challenge of colorectal metastases.Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis.Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab.Hepatic arterial infusion pump chemotherapy for colorectal liver metastases: an old technology in a new era.Systematic review with network meta-analysis: adjuvant chemotherapy for resected colorectal liver metastases.The state of regional therapy in the management of metastatic colorectal cancer to the liver.Circulating tumor cells: what we know, what do we want to know about them and are they ready to be used in clinics?Thromboembolic Events Associated with Bevacizumab plus Chemotherapy for Patients with Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials.Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement.Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.Comparison of cetuximab to bevacizumab as the first-line bio-chemotherapy for patients with metastatic colorectal cancer: superior progression-free survival is restricted to patients with measurable tumors and objective tumor response--a retrospectiLiver-directed therapy in metastatic colorectal cancer.Metastatic Colorectal Cancer to the Liver: Involve the Surgeon Early and Often.The Role of Liver-Directed Therapy in Metastatic Colorectal Cancer
P2860
Q26744398-81ADF6AE-27F7-4087-B90F-15207A322077Q26774704-649E5940-BE99-4C38-B290-9BD4CBE938DAQ26786618-4EDAE5BC-37C3-4EC1-A3D7-9B84F860EBD3Q27014926-8FA73DD5-338D-4A6B-805B-440A1230028AQ30249335-C0283125-0F6F-4201-97A3-FE49D00F8B03Q31060162-42341D80-7751-4504-9779-56309BC138C7Q31127134-083AA02F-C3D8-443E-BFF6-12CB236E19C2Q33422964-7EA69644-9911-4205-9060-D1B3B39F3988Q34630274-9AD205ED-59ED-44F5-9DE6-CF92CB487EE7Q34658579-8DEDE08E-CF48-4A15-B64C-8793DEAED2A0Q35761121-5A29F0D5-999F-4F49-9186-6DBBA6F9B3FCQ35892542-467497E3-20D6-45F0-8087-6A3CE7EF8492Q36071767-84155BED-EBE4-4148-B444-8C78C51C0C3DQ36083102-DA1E9F72-BB80-4DAE-8E81-70A378646AC2Q36097250-51070E67-B10B-4CFC-816D-CBBC6C7BB316Q36097254-AC4095E6-D66B-450F-AB2C-869CA5069D4AQ36609503-C61418C3-5A69-49EA-B580-B5C979916F05Q36838134-CE0A09F9-1094-43A1-A0B6-7B4F835F05C6Q37230612-06D30B0F-C893-450A-B620-33EEA11D90DCQ37361095-25BC7FB3-0553-4FAB-AD6F-0D758EE8EDC8Q37427913-5CF68322-B01B-4931-9673-5481B0D8D57FQ37975507-317D2229-B7B3-48D5-8F44-192D05B101B7Q38051068-8879A176-2F08-46E9-BE71-CA7289914E4AQ38103465-3DFF78C6-307C-4A25-B06A-CCBA1465A610Q38155097-FDE58600-497C-4836-9C44-D38103EF6574Q38187647-4FB9DEF9-D3F4-43EE-87CD-FA5F2CC74797Q38311380-C8D167EB-05CB-4979-A81A-94892A98511DQ38664762-7F5AEE84-7ADA-4D4C-97D9-9CCE323D7610Q38697494-8A3CAD21-FCED-440E-855C-2F72C7FB6CAEQ40975248-0042F3E7-95D3-400E-807E-4FAF33BB1A19Q41946954-1B7DA083-190A-4578-999B-14ECCE9B12C4Q48254405-DCC698E6-9A71-485D-B87C-753989360FD4Q48272442-2CC1AF05-105B-4D7C-877E-822FAEAB07C6Q51842624-D31CD643-668D-41A8-876C-703837B29FE0Q53603379-01820196-5D2C-4AEE-9089-B4DFB948D39BQ57193222-205404A4-B644-493D-A992-63E926437BE5
P2860
Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Randomized phase II trial of a ...... stases from colorectal cancer.
@en
type
label
Randomized phase II trial of a ...... stases from colorectal cancer.
@en
prefLabel
Randomized phase II trial of a ...... stases from colorectal cancer.
@en
P2093
P2860
P921
P356
P1476
Randomized phase II trial of a ...... stases from colorectal cancer.
@en
P2093
Alexandra N Gewirtz
Marinela Capanu
Michael I D'Angelica
Nancy E Kemeny
Ronald P Dematteo
William R Jarnagin
P2860
P304
P356
10.1200/JCO.2010.32.5977
P407
P50
P577
2010-12-28T00:00:00Z